AI Drug Discovery Systems Could Strengthen Biopharmaceutical Innovation—If Policymakers Get the Incentives Right (opens in new tab)

AI systems like Robin could reshape early-stage drug discovery, but only if policymakers support the data, infrastructure, regulatory clarity, and incentives needed to scale them responsibly.